DFX Intelligence
Laurentide Therapeutics Inc.
Venture-backed company · Stage unknown· Atlanta, GA
As of · the latest observation of this company; each round carries its own date
Form D industry: Pharmaceuticals
As of · the latest observation of this company; each round carries its own date
What matters now
- $100Ksold on Form D
Filed a Form D on 20 Aug 2026: $100K sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
Drawing the relationship network…
Facts
Financing history
1 round
- Aug 20, 2026Form D equity offering · $99,999 (form d sold) · 7 investorsFact Form D · “Laurentide Therapeutics Inc. filed Form D: $99,999 sold of $100,000, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.none on record
Outcome stated by investors
No firm portfolio page lists this company, so no outcome is stated.
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.none on record
No lender position matched to this company.
People
1 officer, 0 directors
- Horace Nalle Executive Officer/Director sec.gov
Timeline
2 events
- Sep 28, 2026Horace Nalle is an executive officer of Laurentide Therapeutics Inc. (first Form D 2026-09-28), and was an executive officer of Nutrivert Inc. (first Form D 2023-03-23)Repeat founder Inference
- Sep 28, 2026Laurentide Therapeutics Inc. filed Form D: $99,999 sold of $100,000, PharmaceuticalsForm D filed Fact Form D
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Sep 28, 2026 Fact Form D
- Form D industry group: Pharmaceuticals Sep 28, 2026 Fact Form D
- Amendment: false Sep 28, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Sep 28, 2026 Fact Form D
- Incorporated: withinFiveYears Sep 28, 2026 Fact Form D
- Jurisdiction: Delaware Sep 28, 2026 Fact Form D
- Amount sold (Form D): $99,999 Sep 28, 2026 Fact Form D
- Offering amount (Form D): $100,000 Sep 28, 2026 Fact Form D
- Exemptions: 06b Sep 28, 2026 Fact Form D
- First sale: 2026-08-20 Sep 28, 2026 Fact Form D
- Investors (Form D): 7 Sep 28, 2026 Fact Form D
- Minimum investment (Form D): 0 Sep 28, 2026 Fact Form D
- Securities offered: equity Sep 28, 2026 Fact Form D
- Office address: Sep 28, 2026 Fact Form D
- Year of incorporation: 2026 Sep 28, 2026 Fact Form D
Record history
1 dated event on the change ledger, latest event first
- Form D filed2026-09-28source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.